1. Home
  2. NLSP vs NATR Comparison

NLSP vs NATR Comparison

Compare NLSP & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • NATR
  • Stock Information
  • Founded
  • NLSP 2015
  • NATR 1972
  • Country
  • NLSP Switzerland
  • NATR United States
  • Employees
  • NLSP N/A
  • NATR N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • NATR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NLSP Health Care
  • NATR Health Care
  • Exchange
  • NLSP Nasdaq
  • NATR Nasdaq
  • Market Cap
  • NLSP 12.4M
  • NATR 269.6M
  • IPO Year
  • NLSP 2021
  • NATR N/A
  • Fundamental
  • Price
  • NLSP $2.57
  • NATR $15.17
  • Analyst Decision
  • NLSP
  • NATR Strong Buy
  • Analyst Count
  • NLSP 0
  • NATR 2
  • Target Price
  • NLSP N/A
  • NATR $18.50
  • AVG Volume (30 Days)
  • NLSP 396.2K
  • NATR 113.2K
  • Earning Date
  • NLSP 07-15-2025
  • NATR 08-07-2025
  • Dividend Yield
  • NLSP N/A
  • NATR N/A
  • EPS Growth
  • NLSP N/A
  • NATR N/A
  • EPS
  • NLSP N/A
  • NATR 0.53
  • Revenue
  • NLSP N/A
  • NATR $456,619,000.00
  • Revenue This Year
  • NLSP N/A
  • NATR $3.08
  • Revenue Next Year
  • NLSP N/A
  • NATR $2.41
  • P/E Ratio
  • NLSP N/A
  • NATR $28.55
  • Revenue Growth
  • NLSP N/A
  • NATR 2.00
  • 52 Week Low
  • NLSP $1.30
  • NATR $10.81
  • 52 Week High
  • NLSP $15.59
  • NATR $18.06
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 57.00
  • NATR 59.30
  • Support Level
  • NLSP $2.51
  • NATR $13.39
  • Resistance Level
  • NLSP $3.08
  • NATR $14.92
  • Average True Range (ATR)
  • NLSP 0.23
  • NATR 0.55
  • MACD
  • NLSP 0.02
  • NATR -0.01
  • Stochastic Oscillator
  • NLSP 44.41
  • NATR 85.17

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

Share on Social Networks: